With ever-increasing costs to put a single molecule on the market, the pressure to reach clinical milestones quickly and efficiently often drives a focus on short-term gains that can create ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Having been a French immersion student since the fourth grade, I always thought I’d had a solid command of the language. However, my assurance went out the window whenever I ...

"I just liked working with them so much that I joined them," Chen told BioWorld. Today, Chen is co-CEO of WuXi AppTec. The company, which started with a laboratory of 7,000 square feet, has grown into ...

Although a start-up's recent triumph is seen as a 'DeepSeek moment', domestic players still trail world-beating pharma firms, experts say When Zhao Hong, chief doctor of China's leading cancer ...